Programme : Back to Dr Christian Schueller

Phenotypic discovery and characterization of neuroprotective compounds relevant to ALS


Disease modalities such as Parkinson�s, ALS and Alzheimer�s represent complex neurological disorders where certain neuronal populations decline via only partially understood mechanisms that frequently involve neuro-inflammation.

- Identify new and disease-relevant, neuroprotective compounds for ALS.
- Model the non-cell autonomous nature of ALS by integrating stem cell-derived motor neurons, astrocytes and activated microglia

- Screenable phenotypic assay that uses degeneration of motor neurons as primary readout
Diverse secondary assays for mechanism of action studies

- Identified a small number of neuroprotective compounds in a screen of 11,000 compounds.
- Hit compounds shown to act through multiple
- inhibition of microglial activation,
- directed protection of neurons from NO stress
- glia-specific activation of genes controlled by Nrf2 transcription factor
Add to favourites

Hosted By
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
iPhone App
Android App
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2018